首页> 外文期刊>Journal of cardiac failure >Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group
【24h】

Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group

机译:高血压急性心力衰竭患者的临床和研究注意事项:美国学术急诊医学学会和美国心力衰竭学会急性心力衰竭工作组的共识声明

获取原文
获取原文并翻译 | 示例
           

摘要

Management approaches for patients in the emergency department (ED) who present with acute heart failure (AHF) have largely focused on intravenous diuretics. Yet, the primary pathophysiologic derangement underlying AHF in many patients is not solely volume overload. Patients with hypertensive AHF (H-AHF) represent a clinical phenotype with distinct pathophysiologic mechanisms that result in elevated ventricular filling pressures. To optimize treatment response and minimize adverse events in this subgroup, we propose that clinical management be tailored to a conceptual model of disease based on these mechanisms. This consensus statement reviews the relevant pathophysiology, clinical characteristics, approach to therapy, and considerations for clinical trials in ED patients with H-AHF.
机译:对于急诊(ED)出现急性心力衰竭(AHF)的患者,管理方法主要集中于静脉利尿剂。然而,在许多患者中,AHF的主要病理生理紊乱并不只是容量超负荷。患有高血压AHF(H-AHF)的患者表现出具有明显病理生理机制的临床表型,从而导致心室充盈压升高。为了优化该亚组的治疗反应并最大程度地减少不良事件,我们建议根据这些机制针对疾病的概念模型调整临床管理。该共识性声明回顾了ED-HHF患者的相关病理生理学,临床特征,治疗方法以及临床试验考虑因素。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号